FDA Inspection 1309586 — Nicolas S. Piuzzi, M.D.
The FDA completed an inspection of Nicolas S. Piuzzi, M.D. on March 27, 2026 in Cleveland, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cleveland, OH (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 22727 | 21 CFR 312.64(b) | Safety Reports - Serious Events |
| 22728 | 21 CFR 312.64(b) | Safety Reports - Non-Serious Events |
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |